Oxidative stress may enhance the malignant potential of human hepatocellular carcinoma by telomerase activation - PubMed (original) (raw)
Oxidative stress may enhance the malignant potential of human hepatocellular carcinoma by telomerase activation
Taichiro Nishikawa et al. Liver Int. 2009 Jul.
Abstract
Background/aims: Continuous oxidative stress (OS) plays an important role in the progression of chronic liver diseases and hepatocarcinogenesis through telomere shortening in hepatocytes. However, it has not been established how the OS influences the progression of human hepatocellular carcinomas (HCCs). We examined the correlations of OS with telomere length of cancer cells, telomerase activity and other clinicopathological factors in 68 HCCs.
Methods: The level of 8-hydroxy-2'-deoxyguanosine (8-OHdG) as a marker of OS was examined immunohistochemically and OS was scored in four grades (0-3). The telomere length of cancer cells was measured by quantitative fluorescence in situ hybridization. Telomerase activity was measured by (i) immunodetection of human telomerase reverse transcriptase (hTERT) and (ii) telomere repeat amplification protocol (TRAP) assay. Telomerase related proteins, phosphatase and tensin homolog deleted on chromosome 10 (PTEN) and Akt, and other clinicopathological factors were also evaluated.
Results: As the OS grade increased, the average telomere length became significantly shorter in HCCs, especially in the hTERT-negative group. In the state of high-grade OS, hTERT-positive HCC cells showed more proliferative and less apoptotic features compared with hTERT-negative HCC cells. Telomerase activity, as measured by the TRAP assay, was strongly correlated with OS grade in HCCs. Furthermore, a high OS grade was correlated with the downexpression of PTEN and the activation of Akt.
Conclusions: Oxidative stress enhanced the malignant potential of HCCs through the activation of telomerase, which raises the possibility of using OS as a marker for assessing the clinical state of HCCs.
Similar articles
- Telomere length, TERT and shelterin complex proteins in hepatocellular carcinomas expressing "stemness"-related markers.
Kim H, Yoo JE, Cho JY, Oh BK, Yoon YS, Han HS, Lee HS, Jang JJ, Jeong SH, Kim JW, Park YN. Kim H, et al. J Hepatol. 2013 Oct;59(4):746-52. doi: 10.1016/j.jhep.2013.05.011. Epub 2013 May 14. J Hepatol. 2013. PMID: 23685049 - Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status.
Saini N, Srinivasan R, Chawla Y, Sharma S, Chakraborti A, Rajwanshi A. Saini N, et al. Liver Int. 2009 Sep;29(8):1162-70. doi: 10.1111/j.1478-3231.2009.02082.x. Epub 2009 Jul 17. Liver Int. 2009. PMID: 19627485 - Progressive telomere shortening and telomerase reactivation during hepatocellular carcinogenesis.
Miura N, Horikawa I, Nishimoto A, Ohmura H, Ito H, Hirohashi S, Shay JW, Oshimura M. Miura N, et al. Cancer Genet Cytogenet. 1997 Jan;93(1):56-62. doi: 10.1016/s0165-4608(96)00329-9. Cancer Genet Cytogenet. 1997. PMID: 9062581 - Telomeres and telomerase: a dual role in hepatocarcinogenesis.
Satyanarayana A, Manns MP, Rudolph KL. Satyanarayana A, et al. Hepatology. 2004 Aug;40(2):276-83. doi: 10.1002/hep.20308. Hepatology. 2004. PMID: 15368430 Review. - [Telomere length and telomerase activity in hepatocellular carcinoma].
Nakashio R, Kitamoto M, Nakanishi T, Takaishi H, Takahashi S, Kajiyama G. Nakashio R, et al. Nihon Rinsho. 1998 May;56(5):1239-43. Nihon Rinsho. 1998. PMID: 9613130 Review. Japanese.
Cited by
- Redox Control of the Immune Response in the Hepatic Progenitor Cell Niche.
Bellanti F, Pannone G, Tartaglia N, Serviddio G. Bellanti F, et al. Front Cell Dev Biol. 2020 May 6;8:295. doi: 10.3389/fcell.2020.00295. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32435643 Free PMC article. - Effects of treatment with platinum azidothymidine and azidothymidine on telomerase activity and bcl-2 concentration in hepatocellular carcinoma- induced rats.
Sabokrouh A, Goodarzi MT, Vaisi-Raygani A, Khatami S, Taghizadeh-Jahed M. Sabokrouh A, et al. Avicenna J Med Biotechnol. 2014 Oct;6(4):200-9. Avicenna J Med Biotechnol. 2014. PMID: 25414782 Free PMC article. - L-carnitine prevents progression of non-alcoholic steatohepatitis in a mouse model with upregulation of mitochondrial pathway.
Ishikawa H, Takaki A, Tsuzaki R, Yasunaka T, Koike K, Shimomura Y, Seki H, Matsushita H, Miyake Y, Ikeda F, Shiraha H, Nouso K, Yamamoto K. Ishikawa H, et al. PLoS One. 2014 Jul 1;9(7):e100627. doi: 10.1371/journal.pone.0100627. eCollection 2014. PLoS One. 2014. PMID: 24983359 Free PMC article. - Oxidative stress indicated by elevated expression of Nrf2 and 8-OHdG promotes hepatocellular carcinoma progression.
Ma-On C, Sanpavat A, Whongsiri P, Suwannasin S, Hirankarn N, Tangkijvanich P, Boonla C. Ma-On C, et al. Med Oncol. 2017 Apr;34(4):57. doi: 10.1007/s12032-017-0914-5. Epub 2017 Mar 9. Med Oncol. 2017. PMID: 28281193 - Increased hepatic oxidative DNA damage in patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma.
Tanaka S, Miyanishi K, Kobune M, Kawano Y, Hoki T, Kubo T, Hayashi T, Sato T, Sato Y, Takimoto R, Kato J. Tanaka S, et al. J Gastroenterol. 2013 Nov;48(11):1249-58. doi: 10.1007/s00535-012-0739-0. Epub 2013 Jan 19. J Gastroenterol. 2013. PMID: 23329365
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials